Role of HOMA-IR and IL-6 as screening markers for the metabolic syndrome in patients with chronic schizophrenia: a psychiatric hospital-based cross-sectional study.
Eur Arch Psychiatry Clin Neurosci
; 2023 May 11.
Article
em En
| MEDLINE
| ID: mdl-37166483
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Tipo de estudo:
Diagnostic_studies
/
Observational_studies
/
Prevalence_studies
/
Prognostic_studies
/
Risk_factors_studies
/
Screening_studies
Idioma:
En
Revista:
Eur Arch Psychiatry Clin Neurosci
Ano de publicação:
2023
Tipo de documento:
Article